Community Oncology Alliance (COA)

Latest from Community Oncology Alliance (COA)

How Federal Policy Decisions Are Influencing Cancer Care

November 02, 2020

As novel therapies drive up the cost of cancer care, federal policy decisions are being made that influence oncologists' ability to deliver cancer care, said Debra Patt, MD, PhD, MBA, MPH, of Texas Oncology.

Dr Michael Diaz Outlines Important Lessons Learned From the OCM

April 15, 2020

Networking with other practices, sharing ideas, and getting physicians involved in the process can aid community practices moving to alternative payment models (APMs), said Michael Diaz, MD, president of Community Oncology Alliance.

BOOK REVIEW: One Oncologist's Journey With a Patient to the Outcome We All Face

April 12, 2020

Editor's Note: A book by Kashyap Patel, MD, reviewed in the April issue of Evidence-Based Oncology™, was previously titled, Dying Without Fear. Due to a change by the publisher, Penguin Random House India, the book is now titled Between Life and Death: From Despair to Hope. The book is available August 1, 2020 This review has been updated to reflect the change in the book's title.

Home Infusion Services for Part B Drugs in the Spotlight Amid COVID-19 Regulatory Changes

April 10, 2020

The Community Oncology Alliance (COA) said it is worried that the safety of patients with cancer will be compromised if home infusion regulatory changes, brought about by the coronavirus disease 2019 (COVID-19) pandemic, expand; other groups support the changes, which affect Medicare patients using Part B drugs.